EX-10.8 7 a11-28276_4ex10d8.htm EX-10.8 SUBLICENSE AGREEMENTSublicense Agreement • May 5th, 2020 • England and Wales
Contract Type FiledMay 5th, 2020 JurisdictionTHIS SUBLICENSE AGREEMENT (“Agreement”) effective as of August 27, 2007 (the “Effective Date”) is by and between XENOMICS Inc, a Florida corporation having its principal office at 420 Lexington Avenue Suite 1701 New York, NY 10170 USA, United States of America (“XENOMICS”) and IPSOGEN SAS, a French corporation having its principal office at Luminy Biotech Enterprises Case 923, 163 Avenue de Luminy 13288 Marseille cedex 9 France (“IPSOGEN”).
SUBLICENSE AGREEMENTSublicense Agreement • February 15th, 2012 • TrovaGene Inc. • Biological products, (no disgnostic substances) • England and Wales
Contract Type FiledFebruary 15th, 2012 Company Industry JurisdictionTHIS SUBLICENSE AGREEMENT (“Agreement”) effective as of August 27, 2007 (the “Effective Date”) is by and between XENOMICS Inc, a Florida corporation having its principal office at 420 Lexington Avenue Suite 1701 New York, NY 10170 USA, United States of America (“XENOMICS”) and IPSOGEN SAS, a French corporation having its principal office at Luminy Biotech Enterprises Case 923, 163 Avenue de Luminy 13288 Marseille cedex 9 France (“IPSOGEN”).